Hermetica Superfood Encyclopedia
The Short Answer
Maytenus senegalensis contains a diverse array of triterpenoids (including pristimerin and maytenoic acid), flavonoids, and the macrolide alkaloid maytansine, which exert antiplasmodial, anti-inflammatory, antibacterial, and antiproliferative effects through inhibition of prostaglandin E synthase and disruption of microbial and cell-proliferation pathways. Preclinical in vitro screening of 46 identified compounds and in vivo mouse studies support these activities, though no human clinical trials have been conducted and no standardized therapeutic dose has been established.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordMaytenus senegalensis benefits
Maytenus senegalensis — botanical close-up
Health Benefits
**Antiplasmodial Activity**
Triterpenoids and other phytochemicals from Maytenus senegalensis have demonstrated antiplasmodial properties in in vitro assays, with 46 compounds screened for activity against Plasmodium species, suggesting potential utility in malaria-endemic regions of Africa.
**Anti-Inflammatory Effects**
Molecular docking studies show that triterpenoids pristimerin, isomintlactone, and jacareubin inhibit prostaglandin E synthase, a key enzyme in the inflammatory cascade, providing a mechanistic basis for the plant's traditional use in inflammatory conditions.
**Antibacterial Properties**
Maytenoic acid, isolated from the root bark, and other phytochemicals exhibit antibacterial activity against multiple pathogens, potentially through disruption of bacterial membrane integrity and metabolic pathways.
**Antiproliferative and Antitumor Potential**
Maytansine, a macrolide alkaloid present in the genus Maytenus including M. senegalensis, is recognized for potent antitumor activity, likely via inhibition of tubulin polymerization and disruption of mitotic spindle assembly.
**Oral Health (Chewing Stick Use)**
The plant is traditionally used as a chewing stick in Côte d'Ivoire, with its antibacterial flavonoids, tannins, and phenols potentially reducing oral bacterial load and contributing to dental hygiene through direct antimicrobial contact.
**Antioxidant Activity**: Flavonoids (134
12 ± 0.35 µg/mg, the most abundant phytochemical class identified) and tannins (97.5 ± 0.01 mg TAE/g in leaf ethyl acetate extract) contribute to free-radical scavenging capacity, which may underpin anti-inflammatory and cytoprotective effects.
**Analgesic and Wound-Healing Support**: Saponins (up to 79
1 ± 0.06 mg SQE/g in stem methanol extract) and phenolic compounds contribute to analgesic and tissue-protective properties reported in traditional African ethnomedicine, though these remain unvalidated in controlled human studies.
Origin & History
Natural habitat
Maytenus senegalensis is a thorny shrub or small tree native to sub-Saharan Africa, distributed across Senegal, Côte d'Ivoire, Nigeria, Ethiopia, and East Africa, typically growing in savanna woodland, dry forests, and semi-arid scrublands. The plant thrives in sandy or loamy soils under full sun and is well-adapted to seasonal drought conditions common across the African Sahel and Guinea savanna zones. It is not commercially cultivated at scale but is harvested from wild populations for local medicinal and oral hygiene use.
“Maytenus senegalensis has a long history of use in traditional African medicine across the Sahel, West Africa, and East Africa, where various parts of the plant — roots, bark, leaves, and stems — have been employed to treat fever, malaria, toothache, wounds, and inflammatory conditions. In Côte d'Ivoire specifically, the plant holds cultural significance as a chewing stick, a practice deeply embedded in West African oral hygiene traditions predating modern dentistry, where the fibrous stem releases antibacterial phytochemicals directly against oral pathogens. The plant is referenced in ethnobotanical literature under several regional names and is part of a broader African pharmacopoeia that includes Maytenus species valued across the continent for their diverse therapeutic properties. Its use as a chewing stick parallels that of other African species such as Salvadora persica (miswak), reflecting a widespread continental tradition of plant-based oral care.”Traditional Medicine
Scientific Research
The scientific evidence base for Maytenus senegalensis consists entirely of in vitro experiments and in vivo mouse studies, with no published human clinical trials identified as of the latest available data. A phytochemical profiling study identified 118 biomolecules across plant parts, with 46 compounds tested in vitro for antiplasmodial, anti-inflammatory, and antiproliferative activity using molecular docking and cell-based assays. GC-MS, FTIR, 1H-NMR, and spectrophotometric methods have been used to characterize extract composition, quantifying flavonoids at 134.12 ± 0.35 µg/mg and saponins at 79.1 ± 0.06 mg SQE/g, but no IC50 values or dose-response data from human subjects are available. The overall evidence quality is low by clinical standards, sufficient only to support further preclinical development and not to establish therapeutic recommendations.
Preparation & Dosage
Traditional preparation
**Chewing Stick (Traditional)**
Twigs or stems are cut to approximately 15–20 cm lengths and chewed at the tip to release bioactive compounds directly onto oral mucosa and teeth; no standardized duration or frequency is established.
**Methanol Leaf/Stem Extract (Research)**
Used in laboratory settings at unspecified concentrations for phytochemical assays; not approved or standardized for human supplementation.
**Ethyl Acetate Leaf Extract (Research)**
01 mg TAE/g) and bioactivity screening; not available as a consumer supplement
Employed in tannin quantification (97.5 ± 0..
**Petroleum-Ether Leaf Extract (Research)**
Used for GC-MS profiling of volatile and lipophilic constituents including phytol (1.44–18.62%) and hexadecanoic acid (16.89%); no clinical dose established.
**Root Bark Preparations (Traditional)**
Root bark is used in some African ethnomedicinal traditions as a decoction for infectious or inflammatory conditions; specific preparation ratios and dosing are undocumented in peer-reviewed literature.
**Standardized Supplements**
No commercially standardized supplement form exists; no effective human dose range has been established from clinical trials.
Nutritional Profile
Maytenus senegalensis is not consumed as a food source and has no documented macro- or micronutrient profile relevant to human nutrition. Its bioactive phytochemical composition includes flavonoids at 134.12 ± 0.35 µg/mg (most abundant class), alkaloids at 85.35 ± 0.23 µg/mg, saponins at 69.59 ± 0.35 µg/mg, phenols at 47.40 ± 1.34 µg/mg, and tannins at 32.34 ± 0.78 µg/mg in crude extracts. GC-MS analysis of leaf extracts identifies phytol (a diterpene alcohol, 1.44–18.62%), hexadecanoic acid/palmitic acid (16.89%), 2(4H)-benzofuranone (7.0%), and pristimerin tetraen-carboxylic acid-methyl ester (6.0%) as notable constituents. Bioavailability of these compounds in humans is entirely unknown, as no pharmacokinetic studies have been conducted; tannins and saponins may reduce absorption of co-administered micronutrients through chelation and membrane interaction.
How It Works
Mechanism of Action
Triterpenoids including pristimerin, isomintlactone, and jacareubin have been shown through molecular docking studies to bind and inhibit prostaglandin E synthase, reducing synthesis of prostaglandin E2 and thereby attenuating downstream inflammatory signaling. Maytansine, a macrolide alkaloid found in Maytenus species, exerts antiproliferative and antitumor effects by binding to the vinca domain of tubulin, preventing polymerization and halting cell division at the mitotic spindle checkpoint. Maytenoic acid and related triterpenoids from the root bark disrupt bacterial membrane function and inhibit essential microbial enzymatic processes, accounting for observed antibacterial activity. Flavonoids and tannins contribute to antioxidant effects through direct free-radical scavenging and chelation of pro-oxidant metal ions, while saponins may modulate membrane permeability in both microbial and host cells, amplifying overall bioactivity.
Clinical Evidence
No clinical trials in human subjects have been conducted on Maytenus senegalensis for any indication, including its primary traditional uses as an antimalarial, anti-inflammatory, or oral health agent. Available preclinical evidence derives from in vitro compound screening and unspecified in vivo mouse experiments, neither of which reported formal sample sizes, effect sizes, or statistical confidence intervals in the sources surveyed. The antitumor potential of maytansine is documented from broader genus-level Maytenus research, but M. senegalensis-specific clinical data are absent. Confidence in any therapeutic claim for this plant in humans must therefore be rated as very low, pending well-designed Phase I/II clinical studies.
Safety & Interactions
The safety profile of Maytenus senegalensis in humans is essentially uncharacterized; no formal toxicology studies, adverse event reporting, or maximum tolerated dose data have been published for any extract or isolated compound from this specific species in human subjects. In vivo mouse studies did not report overt toxicity at tested doses, but the absence of reported harm in animal models cannot be extrapolated to human safety without rigorous dose-escalation and pharmacovigilance studies. Maytansine, present in Maytenus species, is known to carry a narrow therapeutic index with significant cytotoxic potential at elevated doses, raising concerns about systemic exposure from concentrated extracts. No specific drug interactions, contraindications, or guidance for use during pregnancy or lactation have been established; in the absence of safety data, use by pregnant or breastfeeding individuals, children, and immunocompromised patients is not advisable.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Maytenus senegalensis (Lam.) ExellGymnosporia senegalensisAfrican spike thornSenegal khat
Frequently Asked Questions
What is Maytenus senegalensis used for traditionally?
Maytenus senegalensis is used traditionally across sub-Saharan Africa for the treatment of fever, malaria, toothache, wounds, and inflammatory conditions. In Côte d'Ivoire, the stems are specifically used as chewing sticks for oral hygiene, releasing antibacterial flavonoids, tannins, and phenols directly onto the teeth and gums. These traditional uses are supported by preliminary phytochemical and in vitro studies but have not been validated in human clinical trials.
What are the main bioactive compounds in Maytenus senegalensis?
Maytenus senegalensis contains 118 identified biomolecules, with the major classes being flavonoids (134.12 ± 0.35 µg/mg), alkaloids (85.35 ± 0.23 µg/mg), saponins (69.59 ± 0.35 µg/mg), phenols (47.40 ± 1.34 µg/mg), and tannins (32.34 ± 0.78 µg/mg). Key individual compounds include the triterpenoids pristimerin, isomintlactone, jacareubin, and maytenoic acid, as well as the macrolide alkaloid maytansine, which has recognized antitumor potential. GC-MS analysis also identifies phytol (up to 18.62%) and hexadecanoic acid (16.89%) in leaf extracts.
Has Maytenus senegalensis been tested in human clinical trials?
No human clinical trials for Maytenus senegalensis have been published as of the current available data. All existing scientific evidence is limited to in vitro experiments — including molecular docking and cell-based assays screening 46 compounds — and unspecified in vivo mouse studies. This means no therapeutic dose, efficacy endpoint, or safety data from human subjects has been established for any indication.
Is Maytenus senegalensis safe to use?
The safety of Maytenus senegalensis for human use has not been formally evaluated; no clinical toxicology studies, adverse event data, or established maximum safe doses exist. While animal studies did not report overt toxicity, this cannot be directly translated to human safety. The presence of maytansine, a potent cytotoxic alkaloid, in the genus raises particular caution about concentrated extract use, and the plant is not recommended for pregnant or breastfeeding individuals until rigorous safety data are available.
What is the anti-inflammatory mechanism of Maytenus senegalensis?
The anti-inflammatory activity of Maytenus senegalensis is primarily attributed to triterpenoids — specifically pristimerin, isomintlactone, and jacareubin — which have been shown through molecular docking studies to inhibit prostaglandin E synthase, the enzyme responsible for converting prostaglandin H2 to the pro-inflammatory mediator prostaglandin E2. Reduction in prostaglandin E2 levels attenuates downstream inflammatory signaling cascades involved in pain, fever, and tissue inflammation. This mechanism provides a plausible molecular basis for traditional anti-inflammatory use, but it has not yet been confirmed in human pharmacological studies.
Does Maytenus senegalensis interact with antimalarial medications?
While Maytenus senegalensis demonstrates antiplasmodial activity in laboratory studies, there is limited clinical data on potential interactions with prescription antimalarial drugs such as artemisinin derivatives or quinine. Anyone taking antimalarial medications should consult a healthcare provider before combining them with Maytenus senegalensis supplements to avoid potential additive effects or altered drug metabolism. The herb's triterpenoids may influence cytochrome P450 enzymes, which metabolize many antimalarial compounds.
Is Maytenus senegalensis appropriate for people in malaria-endemic regions?
Although in vitro screening of 46 compounds from Maytenus senegalensis showed antiplasmodial activity against Plasmodium species, current evidence does not support it as a replacement for proven antimalarial treatments or prevention strategies. The herb may be traditionally used as a complementary approach in African regions where it grows, but its efficacy in living humans for malaria prevention or treatment remains unproven. Clinical trials are needed to determine whether it can provide meaningful protection compared to established antimalarial medications.
What is the evidence quality for Maytenus senegalensis's antiplasmodial effects?
The antiplasmodial evidence for Maytenus senegalensis is currently limited to in vitro laboratory assays, where researchers screened isolated compounds against Plasmodium parasites rather than testing the herb itself in living organisms or human trials. No peer-reviewed human clinical trials have evaluated its efficacy against malaria infection or prevention. To move from preliminary laboratory findings to clinical recommendations, rigorous preclinical studies in animal models and eventually controlled human trials would be necessary.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w maytenus-senegalensis-maytenus-senegalensis curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
